{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:21:02Z","timestamp":1787026862631,"version":"build-2736575974"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    This study aimed to investigate the role of serum levels of transient receptor potential cation channel subfamily V member 1 (TRPV1), vasoacive intestinal peptide (VIP), and pituitary adenylate cyclase-activating polypeptide (PACAP) in the development and also the transformation of migraine in patients suffering from migraine.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Eighty-nine participants with a mean age of 39 years were divided into 23 episodic migraine (EM), 36 chronic migraine (CM), and 30 healthy control groups. Demographic, anthropometric, and headache characteristic information, and also blood samples, was collected. Serum levels of TRPV1, VIP, and PACAP were measured using the enzyme-linked immunosorbent assay (ELISA) technique.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Based on our findings, the serum level of TRPV1 was significantly higher in CM compared to the control group (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.05), whereas serum levels of VIP (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.01) and PACAP (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.05) in the EM group were significantly more than the control group. There was no significant difference between EM and CM groups.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    An elevation in the serum levels of TRVP1 among chronic migraineurs and increments in the levels of VIP and PACAP were observed among EM patients compared to healthy subjects. However, our data failed to demonstrate the probable role of these biomarkers in migraine progression, and more studies are needed to clarify the molecular mechanisms involved in migraine progression.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.770980","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T13:56:39Z","timestamp":1640267799000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of Serum Levels of Transient Receptor Potential Cation Channel Subfamily V Member 1, Vasoactive Intestinal Polypeptide, and Pituitary Adenylate Cyclase-Activating Polypeptide in Chronic and Episodic Migraine: The Possible Role in Migraine Transformation"],"prefix":"10.3389","volume":"12","author":[{"given":"Mansoureh","family":"Togha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Ramazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahime","family":"Zavvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Karimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1526-4610.2006.00443.x","article-title":"Pain characteristics of the acute migraine attack","volume":"46","author":"Kelman","year":"2006","journal-title":"Headache"},{"key":"B2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The international classification of headache disorders, (beta version)","volume":"33","author":"Ettlin","year":"2013","journal-title":"Cephalalgia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1468-2982.1992.1204221.x","article-title":"Migraine with aura and migraine without aura: an epidemiological study","volume":"12","author":"Rasmussen","year":"1992","journal-title":"Cephalalgia."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-019-1066-0","article-title":"Mechanisms of migraine as a chronic evolutive condition","volume":"20","author":"Andreou","year":"2019","journal-title":"J Headache Pain."},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","article-title":"The pathophysiology of migraine: implications for clinical management","volume":"17","author":"Charles","year":"2018","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s10072-019-04021-z","article-title":"Vitamin D in migraine headache: a comprehensive review on literature","volume":"40","author":"Ghorbani","year":"2019","journal-title":"Neurol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-020-01090-w","article-title":"The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo- controlled trial","volume":"21","author":"Ghorbani","year":"2020","journal-title":"J Headache Pain."},{"key":"B9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12883-019-1555-4","article-title":"An investigation of oxidant\/antioxidant balance in patients with migraine: a case-control study","volume":"19","author":"Togha","year":"2019","journal-title":"BMC Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1007\/s11033-020-05781-0","article-title":"Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice","volume":"47","author":"Perez-Pereda","year":"2020","journal-title":"Mol Biol Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/0333102414535111","article-title":"Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine","volume":"35","author":"Cernuda-Morollon","year":"2015","journal-title":"Cephalalgia."},{"key":"B12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nurt.2010.02.003","article-title":"The PACAP receptor: a novel target for migraine treatment","volume":"7","author":"Schytz","year":"2010","journal-title":"Neurotherapeutics."},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","article-title":"PACAP38 induces migraine-like attacks in patients with migraine without aura","volume":"132","author":"Schytz","year":"2009","journal-title":"Brain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-018-0893-8","article-title":"PACAP38 and PAC 1 receptor blockade: a new target for headache?","volume":"19","author":"Rubio-Beltr\u00e1n","year":"2018","journal-title":"Headache."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/13543784.2020.1811966","article-title":"Targeting pituitary adenylate cyclase- activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review","volume":"29","author":"Rustichelli","year":"2020","journal-title":"Expert Opin Investig Drugs."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/acn3.113","article-title":"Pituitary adenylate cyclase activating polypeptide and migraine","volume":"1","author":"Zagami","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","article-title":"Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38","volume":"137","author":"Amin","year":"2014","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/sj.bjp.0705711","article-title":"Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N- arachidonoyl-dopamine and arachidonyl-2-chloroethylamide","volume":"141","author":"Price","year":"2004","journal-title":"Br J Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/ijms21010342","article-title":"Channels in the focus of trigeminal nociceptor sensitization contributing to primary headaches","volume":"21","author":"Dux","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1876386301306010037","article-title":"The role of TRP channels in migraine","volume":"6","author":"Oxford","year":"2013","journal-title":"Open Pain J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11695-017-2793-4","article-title":"Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache","volume":"28","author":"Jahromi","year":"2018","journal-title":"Obes Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrneurol.2012.13","article-title":"Chronic migraine\u2013classification, characteristics and treatment","volume":"8","author":"Diener","year":"2012","journal-title":"Nat Rev Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0333102410383590","article-title":"Chronic migraine: classification and comparisons","volume":"31","author":"Katsarava","year":"2011","journal-title":"Cephalalgia."},{"key":"B25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11916-010-0159-x","article-title":"Treatment of chronic migraine","volume":"15","author":"Hans-Christoph","year":"2011","journal-title":"Current Pain Headache Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1212\/01.wnl.0000262045.11646.b1","article-title":"Obesity, migraine, and chronic migraine: possible mechanisms of interaction","volume":"68","author":"Bigal","year":"2007","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1526-4610.2006.00577.x","article-title":"Modifiable risk factors for migraine progression","volume":"46","author":"Bigal","year":"2006","journal-title":"Headache."},{"key":"B28","first-page":"159","article-title":"Vanilloid (Capsaicin) receptors and mechanisms","volume":"51","author":"Szallasi","year":"1999","journal-title":"Pharmacol Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.molmed.2010.02.004","article-title":"TRPV1 in migraine pathophysiology","volume":"16","author":"Meents","year":"2010","journal-title":"Trends Mol Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0304-3959(03)00159-3","article-title":"Repeated noxious stimulation of the skin enhances cutaneous pain perception of migraine patients in-between attacks: clinical evidence for continuous sub-threshold increase in membrane excitability of central trigeminovascular neurons","volume":"104","author":"Weissman-Fogel","year":"2003","journal-title":"Pain."},{"key":"B31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3988\/jcn.2012.8.2.89","article-title":"Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology","volume":"8","author":"Bernstein","year":"2012","journal-title":"J Clin Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/pme.12767","article-title":"Generalized pressure pain hypersensitivity in the cervical muscles in women with migraine","volume":"16","author":"Florencio","year":"2015","journal-title":"Pain Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/0333102414550417","article-title":"Low heat pain thresholds in migraineurs between attacks","volume":"35","author":"Schwedt","year":"2015","journal-title":"Cephalalgia."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-017-0824-0","article-title":"Characterization of migraineurs presenting interictal widespread pressure hyperalgesia identified using a tender point count: a cross-sectional study","volume":"18","author":"Toriyama","year":"2017","journal-title":"J Headache Pain."},{"key":"B35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1526-4610.2011.01955.x","article-title":"Pathophysiology of chronic migraine and mode of action of preventive medications","volume":"51","author":"Mathew","year":"2011","journal-title":"Headache."},{"key":"B36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1113\/jphysiol.2003.050633","article-title":"Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat","volume":"552","author":"Dux","year":"2003","journal-title":"J Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/sj.bjp.0705896","article-title":"Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors","volume":"142","author":"Akerman","year":"2004","journal-title":"Br J Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nn0602-852","article-title":"Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1","volume":"5","author":"Trevisani","year":"2002","journal-title":"Nat Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-2982.2007.01448.x","article-title":"Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig","volume":"28","author":"Nicoletti","year":"2008","journal-title":"Cephalalgia."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1177\/0333102417748563","article-title":"Ghrelin attenuated hyperalgesia induced by chronic nitroglycerin: CGRP and TRPV1 as targets for migraine management","volume":"38","author":"Farajdokht","year":"2018","journal-title":"Cephalalgia."},{"key":"B41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neures.2013.08.001","article-title":"Activation of extracellular signal-regulated kinase in the trigeminal ganglion following both treatment of the dura mater with capsaicin and cortical spreading depression","volume":"77","author":"Iwashita","year":"2013","journal-title":"Neurosci Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00210-009-0437-5","article-title":"The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission","volume":"380","author":"Lambert","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-015-0539-z","article-title":"Two TRPV1 receptor antagonists are effective in two different experimental models of migraine","volume":"16","author":"Meents","year":"2015","journal-title":"J Headache Pain."},{"key":"B44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1468-2982.1991.1104165.x","article-title":"Evidence for 5-HT1B\/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine","volume":"11","author":"Buzzi","year":"1991","journal-title":"Cephalalgia."},{"key":"B45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1526-4610.2011.02053.x","article-title":"Sumatriptan inhibits TRPV1 channels in trigeminal neurons","volume":"52","author":"Evans","year":"2012","journal-title":"Headache."},{"key":"B46","doi-asserted-by":"publisher","first-page":"G16","DOI":"10.1186\/1129-2377-15-S1-G16","article-title":"EHMTI- 0096. Efficacy of sumatriptan: assessment of a possible biomarker","volume":"15","author":"Ibrahimi","year":"2014","journal-title":"J Headache Pain"},{"key":"B47","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12031-020-01683-9","article-title":"Searching for predictors of migraine chronification: a pilot study of 1911A>G polymorphism of TRPV1 gene in episodic versus chronic migraine","volume":"71","author":"Yakubova","year":"2021","journal-title":"J Mol Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/jnnp-2014-308813","article-title":"TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine","volume":"86","author":"Del Fiacco","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/B978-0-444-53491-0.00016-X","article-title":"Autonomic nervous system control of the cerebral circulation","volume":"117","author":"Goadsby","year":"2013","journal-title":"Handb Clin Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1526-4610.2003.03127.x","article-title":"2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine","volume":"43","author":"Yarnitsky","year":"2003","journal-title":"Headache."},{"key":"B51","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0333102416653232","article-title":"Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: a study in chronic migraine patients","volume":"37","author":"Riesco","year":"2017","journal-title":"Cephalalgia"},{"key":"B52","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/head.12372","article-title":"CGRPand VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine","volume":"54","author":"Cernuda-Moroll\u00f3n","year":"2014","journal-title":"Headache."},{"key":"B53","first-page":"625","article-title":"Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP)","volume":"50","author":"Harmar","year":"1998","journal-title":"Pharmacol Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuropharm.2006.07.017","article-title":"A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC\/PAC receptor pharmacology","volume":"51","author":"Dickson","year":"2006","journal-title":"Neuropharmacology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/10606820213680","article-title":"VPAC receptors for VIP and PACAP","volume":"8","author":"Laburthe","year":"2002","journal-title":"Receptors Channels."},{"key":"B56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jama.1996.03540040063034","article-title":"Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial","volume":"276","author":"Maizels","year":"1996","journal-title":"JAMA."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e42210","DOI":"10.5812\/aapm.42210","article-title":"Parasympathetic cholinergic and neuropeptide mechanisms of migraine","volume":"7","author":"Mikhailov","year":"2017","journal-title":"Anesth Pain Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/0333102416630579","article-title":"Dall'Armi V, Egeo G, Fofi L, Bonassi S. The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization A case series of 757 patients","volume":"36","author":"Barbanti","year":"2016","journal-title":"Cephalalgia."},{"key":"B59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.npep.2014.01.004","article-title":"PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor","volume":"48","author":"Jansen-Olesen","year":"2014","journal-title":"Neuropeptides"},{"key":"B60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.peptides.2011.12.019","article-title":"Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system","volume":"33","author":"Tuka","year":"2012","journal-title":"Peptides."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0333102413483931","article-title":"Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients","volume":"33","author":"Tuka","year":"2013","journal-title":"Cephalalgia."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.770980\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T13:56:43Z","timestamp":1640267803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.770980\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":61,"alternative-id":["10.3389\/fneur.2021.770980"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.770980","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"article-number":"770980"}}